Although the molecular identity of the additional Type 1-positive feedback component involved in the Nutlin-3a response is yet to be determined in further study, the cancer cell lines that we identified to exhibit the novel p53 transitional dynamics under Nutlin-3a treatment provide the model systems to explore and understand this intriguing Type 1-positive feedback target gene of p53 [37–39]. Here, TP53 is linked to cancer.